Resources, Problems and Challenges of Autism Spectrum Disorder Diagnosis and Support System in Poland.
Anna Lenart, Jacek Pasternak
PMID 34345979WHAT IT FOUND
ASD diagnosis in Poland relies heavily on external observation, often missing comorbidities like anxiety or ADHD.
Waiting times are long, and unauthorised screening by teachers is common. Clinicians must differentiate ASD from other disorders and advocate for comprehensive, multi-specialist assessments.
Key findings
01Diagnosis in Poland is often based on external observation of symptoms rather than exploring alternative explanations or the child's internal perspective, leading to potential misdiagnosis.
02Comorbid conditions such as anxiety, ADHD, and intellectual disability are frequently under-diagnosed or overshadowed by the primary ASD diagnosis in Polish clinical documentation.
03Unauthorised diagnosis or suggestion of ASD by non-medical professionals like teachers is a recognised problem, contributing to parental confusion and potential harm.
STILL TO COME
How it was doneWhat they foundWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is an expert opinion and literature review, not an empirical study, so it provides no new data on prevalence or outcomes. The findings are specific to the healthcare and educational system in Poland and may not apply to other countries. The authors rely on their own clinical experience and anecdotal evidence alongside cited literature, which introduces potential bias. The paper notes that the number of institutions audited in the cited reports was too low to draw clear conclusions.
Declared interests
No specific funding or conflicts of interest are declared in the provided text.
The easy way to misread this
Do not interpret this as evidence that ASD is over-diagnosed in Poland. The paper argues that the *process* is flawed and often lacks differential diagnosis, but it does not provide data proving that the prevalence of ASD is artificially inflated. It highlights risks of misdiagnosis and missed comorbidities, not a false-positive epidemic.